- $22.41bn
- $21.91bn
- $606.42m
Insmed jumps after forecasting preliminary 2025 revenue above estimates
U.S. RESEARCH ROUNDUP-Carmax, Cintas, Nike
U.S. STOCKS ON THE MOVE-Cintas, Jabil, Eli Lilly
U.S. STOCKS ON THE MOVE-Accenture, Darden Restaurants, Howard Hughes
U.S. STOCKS ON THE MOVE-Trump Media & Technology, Lululemon, Merck
Insmed dives after sinus drug setback
U.S. RESEARCH ROUNDUP- Autozone, Coursera, Lennar
Insmed scraps development of sinus drug after mid-stage study failure
NASDAQ RESUMED AT 04:35 PM
Brief: Insmed Provides Clinical And Business Update
NASDAQ TRADE HALT HALT NEWS PENDING AT 04:00 PM
Bitcoin hoarding company Strategy remains in Nasdaq 100 (updated)
Brief: Nasdaq Says Biogen, CDW Corporation, Globalfoundries, Lululemon Athletica, On Semiconductor, Trade Desk Will Be Removed From Nasdaq 100 Index
Brief: Insmed Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Insmed Q3 revenue beats estimates
Brief: EMA's CHMP Recommends Against Sanofi's Rezurock
U.S. RESEARCH ROUNDUP- Equifax, Johnson & Johnson, Morgan Stanley
U.S. RESEARCH ROUNDUP- AGCO, Caterpillar, United Rentals
U.S. RESEARCH ROUNDUP- Grail, Maplebear, Ocular Therapeutix